Progressive Care, Inc. (RXMD)
USD 2.11
(5.5%)
USD 2.11
(5.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.64 Million USD | -148.11% |
| 2022 | -5.9 Million USD | -401.34% |
| 2021 | -1.17 Million USD | 18.77% |
| 2020 | -1.44 Million USD | 42.15% |
| 2019 | -2.5 Million USD | -53.77% |
| 2018 | -1.62 Million USD | -3409.1% |
| 2017 | 49.25 Thousand USD | -76.47% |
| 2016 | 209.31 Thousand USD | 117.17% |
| 2015 | -1.21 Million USD | -20.83% |
| 2014 | -1 Million USD | -72.39% |
| 2013 | -585.41 Thousand USD | 0.0% |
| 2011 | -466.29 Thousand USD | -124.98% |
| 2010 | 1.86 Million USD | 1438.15% |
| 2009 | -139.5 Thousand USD | 6.89% |
| 2008 | -149.82 Thousand USD | 13.98% |
| 2007 | -174.18 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.27 Million USD | -2393.55% |
| 2024 Q1 | -372 Thousand USD | 97.2% |
| 2023 Q4 | -13.27 Million USD | -865.48% |
| 2023 Q1 | -424.27 Thousand USD | -108.0% |
| 2023 Q3 | -1.37 Million USD | 70.35% |
| 2023 Q2 | -4.63 Million USD | -992.93% |
| 2023 FY | -19.41 Million USD | -228.85% |
| 2022 Q1 | -2.09 Million USD | -1330.71% |
| 2022 Q2 | -880.72 Thousand USD | 57.86% |
| 2022 Q3 | -541.27 Thousand USD | 38.54% |
| 2022 FY | -5.9 Million USD | -401.34% |
| 2022 Q4 | 5.3 Million USD | 1079.34% |
| 2021 Q4 | -146.09 Thousand USD | -127.65% |
| 2021 Q2 | -191.16 Thousand USD | -425.03% |
| 2021 Q1 | 58.81 Thousand USD | 803.5% |
| 2021 Q3 | 528.39 Thousand USD | 376.41% |
| 2021 FY | -1.17 Million USD | 18.77% |
| 2020 Q2 | -574.54 Thousand USD | 4.89% |
| 2020 Q4 | -8360.00 USD | 96.82% |
| 2020 FY | -1.44 Million USD | 42.15% |
| 2020 Q3 | -262.84 Thousand USD | 54.25% |
| 2020 Q1 | -604.06 Thousand USD | -72.41% |
| 2019 Q3 | -880.77 Thousand USD | -152.77% |
| 2019 FY | -2.5 Million USD | -53.77% |
| 2019 Q4 | -350.37 Thousand USD | 60.22% |
| 2019 Q1 | -751.97 Thousand USD | -21.66% |
| 2019 Q2 | -348.44 Thousand USD | 53.66% |
| 2018 Q4 | -618.09 Thousand USD | -7.96% |
| 2018 Q2 | 203.12 Thousand USD | 131.63% |
| 2018 FY | -1.62 Million USD | -3409.1% |
| 2018 Q1 | -642.29 Thousand USD | -843.23% |
| 2018 Q3 | -572.5 Thousand USD | -381.84% |
| 2017 FY | 49.25 Thousand USD | -76.47% |
| 2017 Q4 | 86.41 Thousand USD | 238.75% |
| 2017 Q3 | -62.28 Thousand USD | 55.05% |
| 2017 Q2 | -138.55 Thousand USD | -184.66% |
| 2017 Q1 | 163.66 Thousand USD | 3051.03% |
| 2016 Q1 | 98.6 Thousand USD | 123.03% |
| 2016 FY | 209.31 Thousand USD | 117.17% |
| 2016 Q3 | -2899.00 USD | -102.43% |
| 2016 Q4 | -5546.00 USD | -91.31% |
| 2016 Q2 | 119.16 Thousand USD | 20.85% |
| 2015 Q1 | -294.26 Thousand USD | -199.31% |
| 2015 FY | -1.21 Million USD | -20.83% |
| 2015 Q2 | -365.34 Thousand USD | -24.15% |
| 2015 Q3 | -160.36 Thousand USD | 56.11% |
| 2015 Q4 | -428.21 Thousand USD | -167.03% |
| 2014 Q2 | -108.17 Thousand USD | 52.4% |
| 2014 Q3 | -575.43 Thousand USD | -431.94% |
| 2014 Q4 | -98.31 Thousand USD | 82.91% |
| 2014 Q1 | -227.25 Thousand USD | 0.0% |
| 2014 FY | -1 Million USD | -72.39% |
| 2013 FY | -585.41 Thousand USD | 0.0% |
| 2012 Q1 | -235.65 Thousand USD | -56.66% |
| 2012 Q2 | -53.46 Thousand USD | 77.31% |
| 2012 Q3 | -364.43 Thousand USD | -581.65% |
| 2011 Q4 | -150.42 Thousand USD | 5.6% |
| 2011 Q3 | -159.34 Thousand USD | -56.58% |
| 2011 Q2 | -101.76 Thousand USD | -85.86% |
| 2011 Q1 | -54.75 Thousand USD | -223.73% |
| 2011 FY | -466.29 Thousand USD | -124.98% |
| 2010 Q4 | 44.25 Thousand USD | 230.71% |
| 2010 Q2 | -18.28 Thousand USD | -51.29% |
| 2010 Q3 | -33.85 Thousand USD | -85.18% |
| 2010 FY | 1.86 Million USD | 1438.15% |
| 2010 Q1 | -12.08 Thousand USD | 55.96% |
| 2009 FY | -139.5 Thousand USD | 6.89% |
| 2009 Q3 | -21.39 Thousand USD | -1.39% |
| 2009 Q4 | -27.44 Thousand USD | -28.27% |
| 2009 Q2 | -21.1 Thousand USD | 39.88% |
| 2009 Q1 | -35.09 Thousand USD | -1.47% |
| 2008 Q4 | -34.59 Thousand USD | 28.99% |
| 2008 Q2 | -21.38 Thousand USD | 60.83% |
| 2008 FY | -149.82 Thousand USD | 13.98% |
| 2008 Q1 | -54.59 Thousand USD | -1.84% |
| 2008 Q3 | -48.71 Thousand USD | -127.77% |
| 2007 FY | -174.18 Thousand USD | 0.0% |
| 2007 Q3 | -20.24 Thousand USD | 77.67% |
| 2007 Q2 | -90.62 Thousand USD | -2685.53% |
| 2007 Q1 | 3505.00 USD | 108.02% |
| 2007 Q4 | -53.6 Thousand USD | -164.86% |
| 2006 Q4 | -43.67 Thousand USD | -0.67% |
| 2006 Q3 | -43.38 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BIMI International Medical Inc. | -22.35 Million USD | 34.469% |
| Leafly Holdings, Inc. | -9.49 Million USD | -54.222% |